EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death

Harri Silvola iD, Lauri Holmström iD, Lasse Pakanen iD, Ida King iD, Anette Eskuri, Jani Tikkanen iD, Juha Perkiömäki iD, Heikki Huikuri iD, Juhani Junttila iD

Europace · 2025

DOI: 10.1093/europace/euaf306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2025. Verfasst von Harri Silvola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Biomedicine and Internal Medicine, Medical Research Center Oulu, University of Oulu, Oulu University Hospital, OYS Sydän, Kajaaninti…. Hauptthemen laut MEDLINE: Death, Sudden, Cardiac, Stroke Volume, Myocardium, Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Left ventricular ejection fraction (LVEF) remains the key determinant in the evaluation for the risk of sudden cardiac death (SCD). Myocardial fibrosis has gained increasingly more interest in the context of various myocardial diseases. We determined the spectrum of LVEF and evaluated the association between myocardial fibrosis and pre-SCD LVEF in a population-based SCD cohort. Methods and results The Fingesture study and clinical data have been collected from consecutive autopsy-verified SCD victims from Northern Finland between 1998 and 2017 (n = 5869). The cause of death was verified in medicolegal autopsy in all subjects. Electronic health records were used to identify those with pre-mortem echocardiography data. The extent of myocardial fibrosis at autopsy was characterized macroscopically and from histology samples. The LVEF recorded median 2 years (interquartile range 1–5) prior to SCD was evaluated in 716 SCD subjects. Proportional LVEF values were as follows: 62.7% (n = 449) normal LVEF (≥50%), 21.9% (n = 157) mildly reduced LVEF (36–49%), and 15.4% (n = 110) severely reduced LVEF (≤35%). At autopsy 19.6% (n = 140) had substantial, 53.8% (n = 386) moderate, and 22.1% (n = 158) mild fibrosis, and 4.5% (n = 32) had no myocardial fibrosis. The extent of myocardial fibrosis and LVEF had poor correlation (Spearman’s ρ 0.21, CI 0.141–0.285, P < 0.001). Only 21.4% of those with substantial fibrosis at autopsy had LVEF ≤35%.

Conclusion

The proportion of SCD subjects with LVEF ≤35% is low, and the prevalence of myocardial fibrosis is high. The LVEF has a weak correlation with the extent of myocardial fibrosis. Our study suggests that LVEF is a poor surrogate of myocardial fibrosis in SCD victims.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Death, Sudden, CardiacStroke VolumeMyocardiumCardiomyopathiesVentricular Function, LeftVentricular Dysfunction, LeftHumansMaleFemaleFibrosisMiddle AgedFinlandAgedAutopsyRisk FactorsAdultEchocardiography

Stichwörter der Autor:innen

Cardiac arrestEchocardiographyEjection fractionMyocardial fibrosisSudden death

Autor:innen und Institutionen

  • Research Unit of Biomedicine and Internal Medicine, Medical Research Center Oulu, University of Oulu, Oulu University Hospital, OYS Sydän, Kajaanintie 50, Oulu 90220, Finland.
  • Forensic Medicine Unit, Finnish Institute for Health and Welfare, Oulu, Finland.
  • Department of Forensic Medicine, Research Unit of Biomedicine and Internal Medicine, Medical Research Center Oulu, University of Oulu, Oulu, Finland.

ORCID-Profile: Harri Silvola, Lauri Holmström, Lasse Pakanen, Ida King, Jani Tikkanen, Juha Perkiömäki, Heikki Huikuri, Juhani Junttila

Förderung

  • Academy of Finland
  • Jane and Aatos Erkko Foundation
  • Sigrid Juselius Foundation
  • Finnish Foundation for Cardiovascular Research
  • Yrjö Jahnsson Foundation
  • Finnish Cultural Foundation
  • Paavo Nurmi Foundation
  • Päivikki ja Sakari Sohlberg Foundation

Zitieren

APA

Silvola, H., Holmström, L., Pakanen, L., King, I., Eskuri, A., Tikkanen, J., Perkiömäki, J., Huikuri, H., & Junttila, J. (2025). Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death. Europace. https://doi.org/10.1093/europace/euaf306

Vancouver

Silvola H, Holmström L, Pakanen L, King I, Eskuri A, Tikkanen J, et al. Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death. Europace. 2025. doi:10.1093/europace/euaf306

BibTeX
@article{Silvola2025,
  author = {Silvola, Harri and Holmström, Lauri and Pakanen, Lasse and King, Ida and Eskuri, Anette and Tikkanen, Jani and Perkiömäki, Juha and Huikuri, Heikki and Junttila, Juhani},
  title = {Left ventricular ejection fraction and myocardial fibrosis in sudden cardiac death},
  journal = {Europace},
  year = {2025},
  doi = {10.1093/europace/euaf306}
}
Kostenlos starten →